Adaptive Virtual Consultation Tool to Enhance Education and Understanding in Patients with Prostate Cancer
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This clinical trial aims to design and validate an adaptive virtual consultation tool (AVCT) for men with prostate cancer (PC). An AVCT utilizes health literacy assessments in combination with learning preferences and individual disease characteristics to provide focused and guided knowledge on PC tailored to the individual patient. Using an AVCT to enhance patient education may improve patient understanding and result in higher patient satisfaction with treatment decisions amongst men with PC.
Full description
PRIMARY OBJECTIVES:
I. To develop an adaptive virtual consultation tool for PC (AVCT):
Ia. To incorporate and integrate the inputs from a diverse group of patients (including minorities), patient advocates, nursing, physicians and education experts in the design process for the adaptive consultation tool; Ib. Employ user centered iterative design approach to develop an adaptive learning tool on mobile devices that is tailored to individuals based on symptoms, health literacy, learning style, and disease specific characteristics.
II. To assess the feasibility, acceptability and usability of AVCT:
IIa. To validate the design approach and customization rules at the completion of the participatory design process using a convenience sample of subjects through assessment of system interaction logs and qualitative feedback from users on cognition, ease-of-use, usability and customization efficacy; IIb. To utilize the feasibility study results in (2a) to refine the interface, information presentation, and adaptive customization approach.
III. To determine the efficacy of AVCT using a small-scale comparative study:
IIIa. To design and execute a three arm comparative study consisting of adaptive virtual consultation, non-adaptive virtual consultation and standard-practice information-only control intervention and assess the comparative efficacy of the tool on the main outcome variable, satisfaction with health care episode; IIIb. To measure changes in other outcome variables at baseline, post-intervention, 3-month and 12-month duration; IIIc. To analyze the mediating influence of decision self-efficacy and a number of moderating factors including preference for decision-making participation and health literacy on outcome variables.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM 1: Patients participate in an adaptive virtual consultation on trial.
ARM 2: Patients participate in a non-adaptive virtual consultation on trial.
ARM 3: Patients receive information-only on trial.
After completion of study intervention, patients are followed up at 3- and 12-months post treatment decision.
Enrollment
Sex
Volunteers
Inclusion criteria
- The participants in this study will be community dwelling, males with prostate cancer (PC) and their healthcare advocate, if applicable
- Proficiency in English is required
Exclusion criteria
- Mental incompetency to participate in the study and/or no treatment option due to other health reasons
Trial design
Primary purpose
Allocation
Interventional model
Masking
18 participants in 3 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal